SBIR/STTR Research Award
Molecular development of peptidic CNS drugs
Award amount
$132,891Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- TERA BIOTECHNOLOGY CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The blood brain barrier (BBB) is a formidable hurdle that limits the clinical potential of most peptides and proteins to treat CNS disease. Most peptides are poorly transported across the BBB thereby limiting their
Technology keywords
Not reported